Biomea Fusion
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biomea Fusion and other ETFs, options, and stocks.About BMEA
Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
BMEA Key Statistics
Stock Snapshot
With a market cap of 94.18M, Biomea Fusion(BMEA) trades at $1.33. The stock has a price-to-earnings ratio of -0.58.
During the trading session on 2026-03-05, Biomea Fusion(BMEA) shares reached a daily high of $1.41 and a low of $1.33. At a current price of $1.33, the stock is +0.2% higher than the low and still -5.5% under the high.
Trading volume for Biomea Fusion(BMEA) stock has reached 442.62K, versus its average volume of 924.68K.
Over the past 52 weeks, Biomea Fusion(BMEA) stock has traded between a high of $3.08 and a low of $0.87.
Over the past 52 weeks, Biomea Fusion(BMEA) stock has traded between a high of $3.08 and a low of $0.87.
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.